www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Dr MedGPT could be omnipresent physician of medical sector in future

By CHENG YU | China Daily | Updated: 2023-08-16 09:24
Share
Share - WeChat
The booth of Medlinker is seen during the 85th Pharmchina, a trade and exchange exhibition platform of the pharmaceutical and healthcare industry, in Shanghai in September 2022. [Photo/China Daily]

"Hi, Dr MedGPT!"

A large number of Chinese patients will soon have their next medical appointment begin with such an opening, as China is giving birth to the first homegrown medical large language model following the late-2022 launch of the United States' Open AI's ChatGPT.

Chinese online healthcare provider Medlinker launched an AI doctor dubbed "MedGPT" earlier this year, which it claims is "just like a human doctor" and can diagnose some of the most common diseases with the same degree of accuracy and consistency as a living, breathing physician.

Unlike general purpose large-scale models, MedGPT was designed to offer practical diagnosis in real medical scenarios, and throughout the entire medical process, from disease prevention to diagnosis, treatment and rehabilitation.

"The integration of AI doctors and telemedicine services is certain to disrupt the entire medical field. At the same time, it will become possible to rapidly replicate high-quality medical resources and make them universally available," said Wang Shirui, founder and CEO of Medlinker.

As some question whether the AI doctor is just a passing tech fad, a real-world assessment took place between MedGPT's AI doctors and human doctors in June. The livestreamed evaluation involved 120 real patients and 10 attending physicians from West China Hospital, Sichuan University.

Seven renowned physicians from leading Chinese hospitals reviewed and scored the results based on criteria including consultation accuracy, diagnosis, treatment recommendations, suggested additional examinations, data analysis, explanations provided to patients, and the use of natural language in patient interactions.

To people's surprise, human doctors scored an average of 7.5 out of 10, while MedGPT scored 7.2.MedGPT's recommendations were found to be 96 percent as good as those from top-tier physicians.

"Looking into the future, we firmly believe that through MedGPT, both the efficiency and the effectiveness of doctors will be vastly enhanced. Furthermore, Medlinker's telemedicine service network will be able to leverage MedGPT to provide more convenient, efficient and accessible medical services to a significantly larger pool of patients while remaining affordable," Wang said.

But MedGPT hasn't yet been put into commercial use. Before it is put into actual practice, more efforts are needed from the government to launch related approvals, guidelines as well as rules for such generative AI tools for healthcare.

The company said it is looking for partnerships with companies and medical institutions to improve AI doctors' accuracy, train them to diagnose more diseases and will run a bigger trial later this year. It also hopes to work with medical experts to establish standards for AI-based healthcare services.

Chinese tech and medical companies are moving aggressively on the technology, while multinational corporations with a business focus on healthcare are sparing no effort to cash in on China's booming AI healthcare market.

According to medical data consultancy Vbdata.cn, the market scale of China's AI-related healthcare industry first exceeded 10 billion yuan ($1.37 billion) last year, and it is expected to grow at a high annual growth rate of 40 percent each year over the next three to five years.

Tencent Holdings, for instance, has developed one of the first AI-based disease management platforms for patients with heart failure. It can use explainable AI technology to warn of disease deterioration, AI-assisted gait analysis to classify the degree of heart failure, and big data to analyze clinical effects.

Zhang Yu, vice-president of Tencent HealthCare, said the accuracy rate of the system in terms of decision support is 90 percent, and it can more accurately evaluate the severity of psoriasis than clinicians.

However, Ma Ting, a professor of neuroinformatics at the Harbin Institute of Technology in Shenzhen, Guangdong province, said that when doctors make decisions as they diagnose patients, they are thinking about multidimensional data.

"But multidimensional data are difficult for AI to access. To fully allow AI to move from its current perceptual intelligence to cognitive intelligence, we still need more research, more data and more intelligent algorithms," Ma said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 91黑丝国产线观看免费 | 国产三级精品91三级在专区 | 成年女人毛片免费播放人 | 国产精品久久久久久亚洲伦理 | 最新国产精品亚洲二区 | 亚洲视频精品在线观看 | 国产在线观看高清不卡 | 狠狠色丁香婷婷综合 | 欧美一级毛片无遮挡 | 亚洲欧美专区精品久久 | 在线国产视频 | 久久99国产乱子伦精品免 | 亚洲欧洲无码一区二区三区 | 欧美成人午夜毛片免费影院 | 中文字幕123区 | 一级做a爰性色毛片免费 | 欧美一级毛片欧美一级成人毛片 | 国产精品久久久久一区二区三区 | 成人精品免费视频 | 在线视频日韩 | 色老汉丁香网 | 亚洲精品国精品久久99热 | 在线毛片一区二区不卡视频 | 欧美成人毛片 | 亚洲风情第一页 | 综合欧美一区二区三区 | 美国一级毛片视频 | 久青草视频在线 | 亚洲一区二区免费 | 亚洲精品综合 | 日本美女黄色一级片 | 99在线视频网站 | 中文字幕1区 | 99视频在线免费看 | 伊大人香蕉久久网欧美 | 精品伊人久久久久网站 | 亚洲视频在线网站 | 欧美综合视频在线观看 | 爽爽日本在线视频免费 | 特黄特黄aaaa级毛片免费看 | 国产成人免费高清视频网址 |